Allurion Technologies, Inc. (ALUR) - Total Assets

Latest as of September 2025: $18.14 Million USD

Based on the latest financial reports, Allurion Technologies, Inc. (ALUR) holds total assets worth $18.14 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See net asset quality index of Allurion Technologies, Inc. to measure how much of total assets are equity-financed.

Allurion Technologies, Inc. - Total Assets Trend (2020–2024)

This chart illustrates how Allurion Technologies, Inc.'s total assets have evolved over time, based on quarterly financial data. Check ALUR cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Allurion Technologies, Inc. - Asset Composition Analysis

Current Asset Composition (December 2024)

Allurion Technologies, Inc.'s total assets of $18.14 Million consist of 82.8% current assets and 17.2% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 46.9%
Accounts Receivable $7.13 Million 21.7%
Inventory $3.40 Million 10.4%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $0.00 0.0%
Goodwill $0.00 0.0%

Asset Composition Trend (2020–2024)

This chart illustrates how Allurion Technologies, Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Allurion Technologies, Inc. (ALUR) market capitalisation.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Allurion Technologies, Inc.'s current assets represent 82.8% of total assets in 2024, an increase from 14.3% in 2020.
  • Cash Position: Cash and equivalents constituted 46.9% of total assets in 2024, up from 14.3% in 2020.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2020.
  • Asset Diversification: The largest asset category is accounts receivable at 21.7% of total assets.

Allurion Technologies, Inc. Competitors by Total Assets

Key competitors of Allurion Technologies, Inc. based on total assets are shown below.

Company Country Total Assets
Double Medical Technology Inc
SHE:002901
China CN¥5.03 Billion
Shenzhen New Industries Biomedical
SHE:300832
China CN¥9.58 Billion
4DMEDICAL Ltd
AU:4DX
Australia AU$139.55 Million
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351
China CN¥2.00 Billion
L&C Bio Co. Ltd
KQ:290650
Korea ₩497.94 Billion
INKON Life Technology Co Ltd
SHE:300143
China CN¥4.17 Billion
Shenzhen Lifotronic Technology Co
SHG:688389
China CN¥2.53 Billion
SS Innovations International Inc. Common Stock
NASDAQ:SSII
USA $90.55 Million

Allurion Technologies, Inc. - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.26 2.33 1.82
Quick Ratio 0.94 2.09 1.82
Cash Ratio 0.00 0.00 0.00
Working Capital $2.98 Million $25.59 Million $622.26K

Allurion Technologies, Inc. - Advanced Valuation Insights

This section examines the relationship between Allurion Technologies, Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio -
Latest Market Cap to Assets Ratio 0.42
Asset Growth Rate (YoY) -54.2%
Total Assets $32.81 Million
Market Capitalization $13.77 Million USD

Valuation Analysis

Below Book Valuation: The market values Allurion Technologies, Inc.'s assets below their book value (0.42x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Allurion Technologies, Inc.'s assets decreased by 54.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Allurion Technologies, Inc. (2020–2024)

The table below shows the annual total assets of Allurion Technologies, Inc. from 2020 to 2024.

Year Total Assets Change
2024-12-31 $32.81 Million -54.24%
2023-12-31 $71.71 Million +39.60%
2022-12-31 $51.37 Million +30.54%
2021-12-31 $39.35 Million +11825.81%
2020-12-31 $329.96K --

About Allurion Technologies, Inc.

NYSE:ALUR USA Medical Devices
Market Cap
$91.85 Million
Market Cap Rank
#26230 Global
#5417 in USA
Share Price
$7.48
Change (1 day)
+1092.79%
52-Week Range
$0.26 - $7.48
All Time High
$10.69
About

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform offers the Allurion Program, a swallowable and procedure-less intragastric balloon for weight loss, as well as provides access to artificial intelligence-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehea… Read more